Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 28;10(5):694. doi: 10.3390/vaccines10050694

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

SARS-CoV-2 receptor binding domain-specific antibody titers in Controls and haemodialysis patients (HD patients, split into responder and low/non-responder groups) 6 months after the second vaccine dose (left) and 6–8 weeks after the third vaccine dose (right). Antibody titers in BAU (binding antibody units) per milliliter. A p value < 0.05 wasconsidered significant; n.s., not significant. The p value in the left figure is for controls vs. all HD patients (responders and low/non-responders combined).